Raquel Alves

Team icon

Researcher

Overview

Raquel Alves, Ph.D., is an Assistant Professor at the Faculty of Medicine, University of Coimbra. She received her Ph.D. in Aging and Chronic Disease from the Faculty of Medicine of the University of Coimbra-FMUC (2020), a master's in Molecular Cell Biology (2011) from the Faculty of Science and Technology of the University of Coimbra, and a degree in Biology (2009) by the same institution. She is a researcher at Coimbra Institute for Clinical and Biomedical Research (iCBR) - Group of Environment Genetics and Oncobiology (CIMAGO) of FMUC and Centre for Innovative Biomedicine and Biotechnology Consortium (CIBB). She is a member of several societies, namely the European Association for Cancer Research (EACR), European Hematology Association (EHA), Portuguese Association for Cancer Research (ASPIC), and Portuguese Hematology Society (SPH), and member of various COST Actions. She currently teaches Applied Molecular Biology and Nutrition Biology, and collaborates in PhD and master courses. She co-supervised 2 bachelor students, 12 MSc (three ongoing), and 1 PhD (ongoing). Raquel Alves (H-index 11 and 272 citations according to Scopus) published 25 completed papers (8 as the first author), three book chapters, and >125 abstracts in international and national journals. She presented more than 250 works at congresses, 197 of them as posters and 60 as oral communication (8 as invited speaker). She participated in 25 projects, in 6 of which she was responsible for the coordination (3 as Principal Investigator and 3 as Co-Principal Investigator), received 23 awards and organized 6 scientific meetings. She was a reviewer for different scientific journals and is the guest editor in 2 special issues. Raquel Alves frequently engages in outreach activities, namely the European Researchers Night and other activities targeted at the general society. Currently, Raquel Alves' research is focusing on molecular and cellular mechanisms of cancer, drug resistance, new biomarkers of susceptibility, diagnosis, prognosis, and therapy response.

Publications

Show less

Information about journal articles, updated at 02-03-2025, from platform CIÊNCIAVITAE.

Novel steroidal oximes as antiproliferative agents: Design, synthesis and biological activity evaluation

Gomes, Ana R.; Tavares-da-Silva, Elisiário J.; Abrantes, Ana M.; Gonçalves, Ana C.; Alves, Raquel; Botelho, Maria F.; Pires, Ana S.; Roleira, Fernanda M.F., Bioorganic Chemistry. 2025. https://doi.org/10.1016/j.bioorg.2025.108229 . 10.1016/j.bioorg.2025.108229 . Bioorganic Chemistry

Batimastat Induces Cytotoxic and Cytostatic Effects in In Vitro Models of Hematological Tumors

Alves, Raquel; Pires, A.; Jorge, J.; Balça-Silva, J.; Gonçalves, A.C.; Sarmento-Ribeiro, A.B., International journal of molecular sciences. 8. 25. 2024. http://www.scopus.com/inward/record.url?eid=2-s2.0-85191622580&partnerID=MN8TOARS . 10.3390/ijms25084554 . published International journal of molecular sciences

Advancements in Biomarkers and Molecular Targets in Hematological Neoplasias

Gonçalves, A.C.; Alves, Raquel; Sarmento-Ribeiro, A.B., International Journal of Molecular Sciences. 12. 25. 2024. http://www.scopus.com/inward/record.url?eid=2-s2.0-85197199666&partnerID=MN8TOARS . 10.3390/ijms25126570 . published International Journal of Molecular Sciences

Steroidal epoxides as anticancer agents in lung, prostate and breast cancers: The case of 1,2-epoxysteroids

Gomes, A.R.; Tavares-da-Silva, E.J.; Costa, S.C.; Varela, C.L.; Abrantes, A.M.; Gonçalves, A.C.; Alves, Raquel; et al, Biochemical Pharmacology. 225. 2024. http://www.scopus.com/inward/record.url?eid=2-s2.0-85193442470&partnerID=MN8TOARS . 10.1016/j.bcp.2024.116266 . published Biochemical Pharmacology

AZD-7648, a DNA-PK Inhibitor, Induces DNA Damage, Apoptosis, and Cell Cycle Arrest in Chronic and Acute Myeloid Leukemia Cells

Lapa, Beatriz Santos; Costa, Maria Inês; Figueiredo, Diana; Jorge, Joana; Alves, Raquel; Monteiro, Ana Raquel; Serambeque, Beatriz; et al, International Journal of Molecular Sciences. 20. 24. 2023. https://doi.org/10.3390/ijms242015331 . 10.3390/ijms242015331 . published International Journal of Molecular Sciences

Monocytes in the Characterization of Pain in Palliative Patients with Severe Dementia—A Pilot Study

Ribeiro, Hugo; Alves, Raquel; Jorge, Joana; Gonçalves, Ana Cristina; Sarmento-Ribeiro, Ana Bela; Teixeira-Veríssimo, Manuel; Andrade, José Paulo; Dourado, Marília, International Journal of Molecular Sciences. 13. 24. 2023. http://dx.doi.org/10.3390/ijms241310723 . 10.3390/ijms241310723 . published International Journal of Molecular Sciences

Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies

Jorge, Joana; Neves, Joana; Alves, Raquel; Geraldes, Catarina; Gonçalves, Ana Cristina; Sarmento-Ribeiro, Ana Bela, International Journal of Molecular Sciences. 11. 24. 2023. http://dx.doi.org/10.3390/ijms24119167 . 10.3390/ijms24119167 . published International Journal of Molecular Sciences

Platelet Membrane Proteins as Pain Biomarkers in Patients with Severe Dementia

Ribeiro, Hugo; Alves, Raquel; Jorge, Joana; Gonçalves, Ana Cristina; Sarmento-Ribeiro, Ana Bela; Teixeira-Veríssimo, Manuel; Dourado, Marília; Andrade, José Paulo, Biomedicines. 2. 11. 2023. https://doi.org/10.3390/biomedicines11020380 . 10.3390/biomedicines11020380 . published Biomedicines

Alvespimycin Inhibits Heat Shock Protein 90 and Overcomes Imatinib Resistance in Chronic Myeloid Leukemia Cell Lines

Alves, Raquel; Santos, Diogo; Jorge, Joana; Gonçalves, Ana Cristina; Catarino, Steve; Girão, Henrique; Melo, Joana Barbosa; Sarmento-Ribeiro, Ana Bela, Molecules. 3. 28. 2023. https://doi.org/10.3390/molecules28031210 . 10.3390/molecules28031210 . published Molecules

Antitumor Effect of Brusatol in Acute Lymphoblastic Leukemia Models Is Triggered by Reactive Oxygen Species Accumulation

Jorge, Joana; Magalhães, Nisa; Alves, Raquel; Lapa, Beatriz; Gonçalves, Ana Cristina; Sarmento-Ribeiro, Ana Bela, Biomedicines. 9. 10. 2022. http://dx.doi.org/10.3390/biomedicines10092207 . 10.3390/biomedicines10092207 . published Biomedicines

Genetic Variants of ABC and SLC Transporter Genes and Chronic Myeloid Leukaemia: Impact on Susceptibility and Prognosis

Alves, Raquel; Gonçalves, Ana Cristina; Jorge, Joana; Marques, Gilberto; Ribeiro, André B.; Tenreiro, Rita; Coucelo, Margarida; et al, International Journal of Molecular Sciences. 17. 23. 2022. http://dx.doi.org/10.3390/ijms23179815 . 10.3390/ijms23179815 . published International Journal of Molecular Sciences

Combination of Elacridar with Imatinib Modulates Resistance Associated with Drug Efflux Transporters in Chronic Myeloid Leukemia

Alves, Raquel; Gonçalves, Ana Cristina; Jorge, Joana; Almeida, António M.; Sarmento-Ribeiro, Ana Bela, Biomedicines. 5. 10. 2022. http://dx.doi.org/10.3390/biomedicines10051158 . 10.3390/biomedicines10051158 . published Biomedicines

Zinc Prevents DNA Damage in Normal Cells but Shows Genotoxic and Cytotoxic Effects in Acute Myeloid Leukemia Cells

Costa, Maria Inês; Lapa, Beatriz Santos; Jorge, Joana; Alves, Raquel; Carreira, Isabel Marques; Sarmento-Ribeiro, Ana Bela; Gonçalves, Ana Cristina, International Journal of Molecular Sciences. 5. 23. 2022. http://dx.doi.org/10.3390/ijms23052567 . 10.3390/ijms23052567 . published International Journal of Molecular Sciences

Can peripheral blood provide good DNA methylation biomarkers in myelodysplastic syndrome?

Jorge, Joana; Gonçalves, Ana Cristina; Cortesão, Emília; Pires, Ana Cláudia; Alves, Raquel; Geraldes, Catarina; Pereira, Amélia; et al, Journal of Molecular and Clinical Medicine. 1. 4. 2021. http://dx.doi.org/10.31083/j.jmcm.2021.01.015 . 10.31083/j.jmcm.2021.01.015 . published Journal of Molecular and Clinical Medicine

Oxidative Stress Parameters Can Predict the Response to Erythropoiesis-Stimulating Agents in Myelodysplastic Syndrome Patients

Gonçalves, Ana Cristina; Alves, Raquel; Baldeiras, Inês; Jorge, Joana; Marques, Bárbara; Paiva, Artur; Oliveiros, Bárbara; et al, Frontiers in Cell and Developmental Biology. 9. 2021. http://dx.doi.org/10.3389/fcell.2021.701328 . 10.3389/fcell.2021.701328 . published Frontiers in Cell and Developmental Biology

Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: From Molecular Mechanisms to Clinical Relevance

Alves, Raquel; Gonçalves, Ana Cristina; Rutella, Sergio; Almeida, António M.; De Las Rivas, Javier; Trougakos, Ioannis P.; Sarmento Ribeiro, Ana Bela, Cancers. 19. 13. 2021. http://dx.doi.org/10.3390/cancers13194820 . 10.3390/cancers13194820 . published Cancers

DNA Methylation Is Correlated with Oxidative Stress in Myelodysplastic Syndrome—Relevance as Complementary Prognostic Biomarkers

Gonçalves, Ana Cristina; Alves, Raquel; Baldeiras, Inês; Marques, Bárbara; Oliveiros, Bárbara; Pereira, Amélia; Nascimento Costa, José Manuel; et al, Cancers. 13. 13. 2021. http://dx.doi.org/10.3390/cancers13133138 . 10.3390/cancers13133138 . published Cancers

Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target

Lapa, Beatriz; Gonçalves, Ana Cristina; Jorge, Joana; Alves, Raquel; Pires, Ana Salomé; Abrantes, Ana Margarida; Coucelo, Margarida; et al, Medical Oncology. 8. 37. 2020. http://dx.doi.org/10.1007/s12032-020-01394-6 . 10.1007/s12032-020-01394-6 . published Medical Oncology

Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-a

Alves, Raquel; McArdle, Stephanie E. B.; Vadakekolathu, Jayakumar; Gonçalves, Ana Cristina; Freitas-Tavares, Paulo; Pereira, Amélia; Almeida, Antonio M.; Sarmento-Ribeiro, Ana Bela; Rutella, Sergio, Journal of Translational Medicine. 1. 18. 2020. http://dx.doi.org/10.1186/s12967-019-02194-x . 10.1186/s12967-019-02194-x . published Journal of Translational Medicine

MicroRNA signature refine response prediction in CML

Alves, Raquel; Gonçalves, Ana Cristina; Jorge, Joana; Marques, Gilberto; Luís, D.; Barbosa-Ribeiro, André; Freitas-Tavares, Paulo; et al, Scientific Reports. 1. 9. 2019. http://www.scopus.com/inward/record.url?eid=2-s2.0-85068470311&partnerID=MN8TOARS . 10.1038/s41598-019-46132-9 . published Scientific Reports

Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia

Alves, Raquel; Gonçalves, Ana Cristina; Jorge, Joana; Alves, Joana; Alves da Silva, António; Freitas-Tavares, Paulo; Nascimento-Costa, José Manuel; Almeida, António; Sarmento-Ribeiro, Ana Bela, Medical Oncology. 3. 36. 2019. http://www.scopus.com/inward/record.url?eid=2-s2.0-85061978734&partnerID=MN8TOARS . 10.1007/s12032-019-1253-5 . published Medical Oncology

Apoptosis induction and cell cycle arrest of pladienolide B in erythroleukemia cell lines

Jorge, Joana; Petronilho, Sara; Alves, Raquel; Coucelo, Margarida; Gonçalves, Ana Cristina; Nascimento-Costa, José Manuel; Sarmento-Ribeiro, Ana Bela, Investigational New Drugs. 2019. http://www.scopus.com/inward/record.url?eid=2-s2.0-85066463071&partnerID=MN8TOARS . 10.1007/s10637-019-00796-2 . published Investigational New Drugs

Tissular growth factors profile after teduglutide administration on an animal model of intestinal anastomosis,Perfil tisular de factores de crecimiento postadministración de teduglutida en un modelo animal de anastomosis intestinal

da Costa, Beatriz; Gonçalves, Ana Cristina; Abrantes, Ana Margarida; Alves, Raquel; Matafome, Paulo; Sarmento-Ribeiro, Ana Bela; Botelho, Maria Filomena; Castro-Sousa, Francisco, Nutricion Hospitalaria. 185 - 193. 1. 35. 2018. http://www.scopus.com/inward/record.url?eid=2-s2.0-85044216245&partnerID=MN8TOARS . 10.20960/nh.1326 . published Nutricion Hospitalaria

Intestinal Epithelial Stem Cells: Distinct Behavior After Surgical Injury and Teduglutide Administration

Costa, Beatriz P.; Gonçalves, Ana C.; Abrantes, Ana M.; Alves, Raquel; Matafome, Paulo; Seiça, Raquel; Sarmento-Ribeiro, Ana B.; Botelho, M. Filomena; Castro-Sousa, Francisco, Journal of Investigative Surgery. online. 2017. 10.1080/08941939.2017.1294217 . published Journal of Investigative Surgery

Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis

Gonçalves, Ana Cristina; Alves, Raquel; Baldeiras, Inês; Cortesão, Emília; Carda, José Pedro; Branco, Claudia C.; Oliveiros, B.; et al, Molecular Carcinogenesis. 130 - 148. 1. 56. 2016. http://onlinelibrary.wiley.com/doi/10.1002/mc.22478/full . 10.1002/mc.22478 . published Molecular Carcinogenesis

Drug transporters play a key role in the complex process of Imatinib resistance in vitro

Alves, Raquel; Fonseca, Ana Raquel; Goncalves, Ana C.; Ferreira-Teixeira, Margarida; Lima, Joana; Abrantes, Ana M.; Alves, Vera; et al, Leukemia Research. 355 - 360. 3. 39. 2015. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349957800016&KeyUID=WOS:000349957800016 . 10.1016/j.leukres.2014.12.008 . published Leukemia Research

Chemical characterization and cytotoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves

Liberal, Joana; Costa, Gustavo; Carmo, Anália; Vitorino, Rui; Marques, Carla; Domingues, Maria Rosário; Domingues, Pedro; et al, Arabian Journal of Chemistry. 1 - 15. Online. 2015. 10.1016/j.arabjc.2015.11.014 . published Arabian Journal of Chemistry

Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma

Mamede, Ana; Guerra, S.; Laranjo, Mafalda; Carvalho, Maria João; Oliveira, R.C.; Gonçalves, Ana Cristina; Alves, Raquel; et al, Medical Oncology. 257 - 257. 12. 32. 2015. http://link.springer.com/article/10.1007%2Fs12032-015-0702-z . 10.1007/s12032-015-0702-z . published Medical Oncology

L744,832 and Everolimus Induce Cytotoxic and Cytostatic Effects in Non-Hodgkin Lymphoma Cells

Mendes, José; Gonçalves, Ana Cristina; Alves, Raquel; Jorge, Joana; Pires, Ana; Ribeiro, A.; Sarmento-Ribeiro, Ana Bela, Pathology & Oncology Research. 301 - 309. 2. 22. 2015. 10.1007/s12253-015-9998-4 . published Pathology & Oncology Research

All projects

Show less

Information of exclusive responsibility of the researcher 02-03-2025 , from platform CIÊNCIAVITAE.

2025 -

Interrogation of the immune-microenvironment of T-cell malignancies

ImmuneT-ME

Researcher

Universidade de Coimbra Faculdade de Medicina

Funders: Comissão de Coordenação e Desenvolvimento Regional do Centro

2024 -

Relevance of NF-kB and NRF2/KEAP1 pathways as biomarkers of drug response in patients with Multiple Myeloma

LPCC/GSK

Principal investigator

Funders: Liga Portuguesa Contra o Cancro; GlaxoSmithKline Produtos Farmacêuticos Lda

2023 -

Relevância clínica das plaquetas como biomarcadores não invasivos no Mieloma Múltiplo - Um estudo piloto

APCL 2023

Researcher

Associação Portuguesa Contra a Leucemia; Sociedade Portuguesa de Hematologia; Amgen Biofarmaceutica Lda

2023 -

Clinical Relevance of non-invasive biomarkers in bone and soft tissue tumors

NRC-LPCC/CIMAGO 2023

Researcher

Liga Portuguesa Contra o Cancro Núcleo Regional do Centro

2023 -

Circular RNAs in hematological neoplasms: Potential biomarker from diagnosis to therapy

NRC-LPCC/CIMAGO 2023

Principal investigator

Liga Portuguesa Contra o Cancro Núcleo Regional do Centro

2022 -

Crosstalk Between Mutation Landscape, Immune Dysregulation And Microbiome - Role In Pathogenesis And Progression Of Myeloproliferative Neoplasms

01/23

Researcher

Sociedade Portuguesa de Hematologia

2022 -

Molecular therapeutic targets in IDH1/2 mutant AML: exploring the links between metabolism and DNA

02/23

Researcher

Sociedade Portuguesa de Hematologia

2022 -

HemaCirc: circular RNAs as an innovative tool in hematological neoplasms

CIMAGO 08/22

Principal investigator

Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2022 -

The role of platelets in diagnosis, prognosis and therapeutic monitoring in diffuse large B-cell lymphoma

CIMAGO 06/22

Researcher

Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2022 -

Evaluation of molecular mechanisms of resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma

CIMAGO 05/22

Researcher

Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2022 -

Synthetic lethality in acute myeloid leukemia - Role of DNA damage response

CIMAGO 04/22

Researcher

Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2021/01/01 - 2025/12/31

Center for Innovative Biomedicine and Biotechnology - Associate Laboratory

LA/P/0058/2020

Universidade de Coimbra; Universidade Nova de Lisboa ¿Laboratório de Instrumentação Engenharia Biomédica e Física da Radiação; Universidade de Coimbra Centro de Neurociências e Biologia Celular

Funders: Fundação para a Ciência e a Tecnologia

2019 -

EPO-EPOR axis in MDS - Clinical relevance as prognostic and drug response biomarker

Project 02/19

Researcher

Funders: Sociedade de Portuguesa de Hematologia

2019 -

Red Transfronteriza de Innovación en Diagnóstico Precoz de Leucemia para un envejecimiento saludable (IDIAL-NET )

IDIAL-NET

Researcher

2018 -

NRF2-KEAP1 axis as a new potential prognostic biomarker in chronic lymphocytic leukemia

Project 03/18

Researcher

Universidade de Coimbra Faculdade de Medicina

Funders: Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2018 -

Epigenetic in Chronic Lymphocytic Leukemia B – Impact in prognosis and therapy

Project 02/18

Researcher

Universidade de Coimbra Faculdade de Medicina

Funders: Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2018 -

Identification of new response markers to Bortezomib and Lenalidomide in patients with multiple myeloma – The role of NF-kB and NRF2/KEAP1

Project 04/18

Researcher

Universidade de Coimbra Faculdade de Medicina

Funders: Liga Portuguesa Contra o Cancro; Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2016 - 2018

The role of microRNAs for chronic myeloid leukemia therapeutic selection

Project FMUC-BST-2016-214

Researcher

Universidade de Coimbra Faculdade de Medicina

Funders: Universidade de Coimbra Faculdade de Medicina; Banco Santander Totta

2014 - 2018

The role of MicroRNAs for therapeutic selection in BCR-ABL+ Leukemias

Project 10/14

Researcher

Universidade de Coimbra Faculdade de Medicina

Funders: Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2012 - 2015

Avaliação da relação entre o stress oxidativo e modulação epigenética em neoplasias hematológicas - Papel da variabilidade genética/epigenética no risco de desenvolver neoplasias hematológicas e/ou resistência ao tratamento

Project 22/09

Researcher

Universidade de Coimbra Faculdade de Medicina

Funders: Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2012 - 2015

Alterações celulares e moleculares no Mieloma Múltiplo – Implicações clínicas e terapêuticas

Project 23/09

Researcher

Universidade de Coimbra Faculdade de Medicina

Funders: Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2012 - 2014

Caracterização clínica e molecular da síndrome mielodisplásica - papel da apoptose e dos microRNAs no prognóstico e terapêutica

Project 24/09

Researcher

Universidade de Coimbra Faculdade de Medicina

Funders: Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2012 - 2013

The cross-talk between oxidative stress and epigenetics – A possible route in myeloid leukaemia

Project GAI-FMUC

Researcher

Universidade de Coimbra Faculdade de Medicina

Funders: Universidade de Coimbra Faculdade de Medicina; Banco Santander Totta

2012 - 2020

Characterization of Cellular and Molecular mechanisms involved in Sensitivity and Resistance to BCR-ABL targeted therapies in Chronic Myelogenous

Project 18/12

Researcher

Universidade de Coimbra Faculdade de Medicina

Funders: Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

2012 - 2019

Modulação redox em neoplasias hematológicas – o NRF2 como novo marcador e alvo terapêutico

Project 10/12

Researcher

Funders: Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

We use cookies to improve your visit to our website.